1. Home
  2. PXLW vs CVM Comparison

PXLW vs CVM Comparison

Compare PXLW & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

HOLD

Current Price

$6.41

Market Cap

43.5M

Sector

Technology

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$6.22

Market Cap

43.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXLW
CVM
Founded
1997
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.5M
43.3M
IPO Year
2000
1987

Fundamental Metrics

Financial Performance
Metric
PXLW
CVM
Price
$6.41
$6.22
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$14.33
N/A
AVG Volume (30 Days)
85.6K
63.9K
Earning Date
02-11-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,205,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.67
$1.98
52 Week High
$15.42
$20.41

Technical Indicators

Market Signals
Indicator
PXLW
CVM
Relative Strength Index (RSI) 45.29 56.77
Support Level $6.33 $4.90
Resistance Level $7.15 $6.56
Average True Range (ATR) 0.40 0.63
MACD -0.01 0.15
Stochastic Oscillator 12.93 73.13

Price Performance

Historical Comparison
PXLW
CVM

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: